S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

vTv Therapeutics (VTVT) Earnings Date, Estimates & Call Transcripts

$24.74
+0.59 (+2.44%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 13)
-$1.67 Missed By -$1.67
Skip Charts & View Estimated and Actual Earnings Data

VTVT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VTVT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

VTVT Earnings Date and Information

vTv Therapeutics last released its quarterly earnings results on March 13th, 2024. The biotechnology company reported ($1.67) earnings per share for the quarter. vTv Therapeutics has generated ($10.07) earnings per share over the last year (($10.07) diluted earnings per share). vTv Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

vTv Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/13/2024Q4 2023-($1.67)($1.67)($1.67)--
11/9/2023Q3 2023-($3.20)($3.20)($3.20)--
8/11/2023Q2 2023-($2.80)($2.80)($0.07)--
5/11/2023Q1 2023($3.20)($2.40)+$0.80($0.06)--
3/6/2023-($2.40)($2.40)-($0.06)-$0.01 million
11/10/2022Q3 2022($2.00)($2.00)-($0.05)--
8/15/2022Q2 2022($4.00)($1.60)+$2.40($0.04)-$0.01 million
5/12/2022Q1 2022($3.20)($4.00)($0.80)($0.10)-$2.00 million
3/29/2022Q4 2021($3.20)($3.20)-($0.05)$1.00 million$0.01 million
11/9/2021Q3 2021($2.80)($0.80)+$2.00($0.02)$1.30 million$3.00 million
8/4/2021Q2 2021($2.80)($0.40)+$2.40($0.01)$1.00 million$0.01 million
5/5/2021Q1 2021($2.40)($3.60)($1.20)($0.10)$0.80 million$0.99 million

vTv Therapeutics Earnings - Frequently Asked Questions

When is vTv Therapeutics's earnings date?

vTv Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on VTVT's earnings history.

How much revenue does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded annual revenue of $2.02 million.

How much profit does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded net income of -$20.25 million. VTVT has generated -$10.07 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:VTVT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners